Overview

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 2, Therapeutic Exploratory Study)

Status:
Completed

Trial end date:
2018-04-18

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the efficacy and safety of DWP14012 compared to esomeprazole in the treatment of erosive gastroesophageal reflux disease classified as Los Angeles(LA) classification grades A to D.

Phase:

Phase 2

Details

Lead Sponsor:

Daewoong Pharmaceutical Co. LTD.

Treatments:

Esomeprazole